Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ARQT

Arcutis Biotherapeutics Inc

May 29 • 04:00PM ET

21.46

+0.02 0.09 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: KRYS MANE ORKA BMRN RYTM VKTX INCY AXSM MDGL NBIX

| Held by: XBI VTI IWM VXF IWO IBB VTWO SCHA VHT FESM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.03	Insider Own	11.72%	Shs Outstand	125.04M	Perf Week	2.14%
Market Cap	2.68B	Forward P/E	20.08	EPS next Y	1.07	Insider Trans	-1.79%	Shs Float	110.42M	Perf Month	-4.07%
Enterprise Value	2.57B	PEG	-	EPS next Q	0.04	Inst Own	98.40%	Short Float	15.89%	Perf Quarter	-20.43%
Income	-2.38M	P/S	6.46	EPS this Y	253.13%	Inst Trans	1.17%	Short Ratio	11.37	Perf Half Y	-30.17%
Sales	415.62M	P/B	14.15	EPS next Y	436.89%	ROA	-0.59%	Short Interest	17.55M	Perf YTD	-26.10%
Book/sh	1.52	P/C	11.97	EPS next 5Y	-	ROE	-1.43%	52W High	31.77 -32.45%	Perf Year	56.99%
Cash/sh	1.79	P/FCF	99.71	EPS past 3/5Y	71.80% 49.34%	ROIC	-0.80%	52W Low	12.72 68.71%	Perf 3Y	155.48%
Dividend Est.	-	EV/EBITDA	417.96	Sales past 3/5Y	367.27% -	Gross Margin	90.94%	Volatility	3.44% 5.30%	Perf 5Y	-18.56%
Dividend TTM	-	EV/Sales	6.19	EPS Y/Y TTM	98.21%	Oper. Margin	0.77%	ATR (14)	1.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.46	Sales Y/Y TTM	95.29%	Profit Margin	-0.57%	RSI (14)	47.40	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	2.68	EPS Q/Q	56.09%	SMA20	-0.14%	Beta	1.52	Target Price	34.62
Payout	-	Debt/Eq	0.60	Sales Q/Q	60.07%	SMA50	-5.12%	Rel Volume	1.02	Prev Close	21.44
Employees	354	LT Debt/Eq	0.56	Earnings	May 06 AMC	SMA200	-8.58%	Avg Volume	1.54M	Price	21.46
IPO	Jan 31, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-39.97% 1.66%	Trades		Volume	1,578,986	Change	0.09%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)